Comportamiento del índice de TEI en semana 11 a la 14 en fetos sanos
Fecha
2013-12-16Registro en:
Paladini D., Volpo P.. Ultrasound of congenital fetal anomalies. Informal
Hearthcare. London, 2007; pp.113-182
Meberg A., Otterstard J., Froland G., Lindberg H., Orland S.. Outcome of
congenital heart defect – a population - based study. Acta Pediatr. 2000; 89:
1344-55.
Allan L., Sharland G., Milburn A., Lockhart S., Groves A., Anderson R., Cook
A.. Prospective diagnosis of 1006 consecutive cases of congenital heart
disease in the fetus. J.Am.Coll.Card. 1994; 23: 1452-8.
Nicolaides O., Falcon O.. La ecografiade las 11 -13+6 semanas. Fetal Medical
Fundation. 2004
Fliedner R. , Chiriac A., Hartge D., Krapp M., et.al. Fetal cardiac abnormalities
identified prior to 14 weeks gestation. Ultrasound in Obstetrics and Gynecology
2008; 32: 333.
Bartrons J.. Ecografia fetal. Exámen de la anatomía y circulación normal del
feto. Libro de Protocolos. Sociedad Española de Cardiología Pediátrica y
Cardiopatías Congénitas. Cap. 48 pp: 713-730.
www.secardioped.org/protocolos. 2009.
Rosano A., Botto L., Botting B., Mastroiacovo P. Infant mortality and
congenital anomalies from 1950 to1994: an international perspective. J.
Epidemiol. Community Healt- 2000; 54:660-6.
Mortera C., Maroto C.. Ecocardiografía Doppler de la circulación fetal. En:
García Fernandez M.A.. Principios y práctica del Doppler cardíaco. Madrid:
McGraw-Hill. 1995; p365-89.
Allan L., Hornberger L., Sharland G.. Textbook of fetal cardiology 2000;
Greenwick Medical Medial Limited. London.
Crispi F., Gómez O., Bennasar M. Martínez J. Protocolo Ecocardiografía
Funcional Fetal. Unidad de Cardiología Fetal, Sección de Ecografía, Área de
Medicina Fetal, Servicio de Medicina Materno-Fetal. Institut Clínic de
Ginecologia, Obstetrícia y Neonatologia, Hospital Clínic de Barcelona
Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ et al. New index
of combined systolic and diastolic myocardial performance: a simple and
reproducible measure of cardiac function-a study in normals and dilated
cardiomyopathy. J Cardiol 1995; 26: 357-66.
Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB. Doppler index
combining systolic and diastolic myocardial performance: clinical value in
cardiac amyloidosis. J Am Coll Cardiol 1996; 28: 658-64.
Torres-Rojo YI y cols. Índice de funcionamiento miocárdico global con
ecocardiografía Doppler Rev Mex Cardiol 2005; 16 (2): 60-64
Friedman D, Buyon J, Kim M, Glickstein JS. Fetal cardiac function assessed by
Doppler myocardial performance index (Tei Index). Ultrasound Obstet Gynecol
2003; 21: 33–36
Raboisson MJ, Bourdages M, Fouron JC. Measuring left ventricular myocardial
performance index in fetuses. Am J Cardiol 2003; 91: 919–921.
Carvalho JS, Moscoso G, Ville Y. First-trimester transabdominal
echocardiography. Lancet 1998; 351: 1023–1027
Haak MC, Bartelings MM, Gittenberger-de Groot AC, van Vugt JM. Cardiac
malformations in first-trimester fetuses with increased nuchal translucency:
ultrasound diagnosis and
postmortem morphology. Ultrasound Obstet Gynecol 2002; 20: 14–21.
Weiner Z, Lorber A, Shalev E. Diagnosis of congenital cardiac defects between
11 and 14 weeks’ gestation in high-risk patients. J Ultrasound Med 2002; 21:
23–29
Huggon IC, Ghi T, Cook AC, Zosmer N, et.al.. Fetal cardiac abnormalities
identified prior to 14 weeks’ gestation. Ultrasound Obstet Gynecol 2002;
20:22–29.
McAuliffe FM, Hornberger LK, Winsor S, Chitayat et.al.. Fetal cardiac defects
and increased nuchal translucency thickness: a prospective study. Am J
Obstet Gynecol 2004; 191: 1486–1490.
Rasiah SV, Publicover M, Ewer AK, Khan KS, et.al.. A systematic review of the
accuracy of first- trimester ultrasound examination for detecting major
congenital heart disease. Ultrasound Obstet Gynecol 2006; 28: 110–116.
Leiva MC, Tolosa JE, Binotto CN, Weiner S, et.al.. Fetal cardiac development
and hemodynamics in the first trimester. Ultrasound Obstet Gynecol 1999; 14:
169–174.
Makikallio K, Jouppila P, Rasanen J.. Human fetal cardiac function during the
first trimester of pregnancy. Heart 2005; 91: 334–338.
Wloch A, Rozmus Warcholinska W, Czuba B, Borowski D,et.al.. Doppler study
of the embryonic heart in normal pregnant women. J Matern Fetal Neonatal
Med 2007; 20: 533–539.
van Splunder I., Wladimiroff W. Cardiac functional changes in the human fetus
in the late first and early second trimesters. Ultrasound Obstet Gynecol 1996;
7: 411–415
Hata T, Inubashiri E, Kanenishi K, Akiyama M,et.al.. Nuchal translucency
thickness and fetal cardiac flow velocity in normal fetuses at 11–13 weeks of
gestation. Gynecol Obstet Invest 2002; 53: 209–213
Huggon IC, Turan O, Allan LD. Doppler assessment of cardiac function at 11–
14 weeks’ gestation in fetuses with normal and increased nuchal translucency.
Ultrasound Obstet Gynecol 2004; 24: 390–398
Haak MC, Twisk JW, Bartelings MM, Gittenberger-de Groot AC, et.al. First
trimester fetuses with increased nuchal translucency do not show altered
intracardiac flow velocities. Ultrasound Obstet Gynecol 2005; 25: 215–220
Russel NE, McAuliffe FM. First-trimester fetal cardiac function. J Ultrasound
Med 2008; 27: 379–383.
Huhta JC. Fetal congestive heart failure. Semin Fetal Neonatal Med 2005; 10:
542–552
Paladini D, Chita SK, Allan LD. Prenatal measurement of cardiothoracic ratio in
evaluation of heart disease. Arch Dis Child 1990; 65: 20–23.
Chaoui R, Bollmann R, Goldner B, Heling KS, et.al.. Fetal cardiomegaly:
echocardiographic findings and outcome in 19 cases. Fetal Diagn Ther 1994;
9: 92–104.
Gembruch U, Shi C, Smrcek JM. Biometry of the fetal heart between 10 and 17
weeks of gestation. Fetal Diagn Ther 2000; 15: 20–31.
Tongsong T, Tatiyapornkul T. Cardiothoracic ratio in the first half of pregnancy.
J Clin Ultrasound 2004; 32: 186–189.
Awadh AM, Prefumo F, Bland JM, Carvalho JS. Assessment of the
intraobserver variability in the measurement of fetal cardiothoracic ratio using
ellipse and diameter methods. Ultrasound Obstet Gynecol 2006; 28: 53–56.
Stark RI, Myers MM, Daniel SS, Garland M, et.al.. Gestational age related
changes in cardiac dynamics of the fetal baboon. Early Hum Dev 1999; 53:
219–237.
Vimpeli T, Huhtala H, Wilsgaard T, Acharya G. Fetal cardiac output and its
distribution to the placenta at 11–20 weeks of gestation. Ultrasound Obstet
Gynecol 2009; 33: 265–271.
Kenny J, Plappert T, Doubilet P, Salzman D, et.al.. Effects of heart rate on
ventricular size, stroke volume, and output in the normal human fetus: a
prospective Doppler echocardiographic study. Circulation 1987; 76: 52–58.
Acharya G, Rasanen J, Kiserud T, Huhta JC. The fetal cardiac function. Curr
Cardiol Rev 2006; 2: 41–53.
Hernandez E., Lopez J., Figueroa H., Sanin .J, et.al.. A modified myocardial
performance (Tei) index based on the use of valve clicks improves
reproducibility of fetal left cardiac function
assessment. Ultrasound Obstet Gynecol 2005; 26: 227–232
Raboisson MJ, Bourdages M, Fouron JC. Measuring left ventricular myocardial
performance index in fetuses. Am J Cardiol 2003; 91: 919–921.
Tsutsumi T, Ishii M, Eto G, Hota M, et.al.. Serial evaluation for myocardial
performance in fetuses and neonates using a new Doppler index. Pediatr Int
1999; 41: 722–727.
Eidem BW, Edwards JM, Cetta F. Quantitive assessment of fetal ventricular
function. Echocardiography 2001; 1: 9–13.
Friedman D, Buyon J, Kim M, Glickstein JS. Fetal cardiac function assessed by
Doppler myocardial performance index (Tei Index). Ultrasound Obstet Gynecol
2003; 21: 33–36.
Huhta JC. Guidelines for the evaluation of heart failure in the fetus with or
without hydrops. Pediatr Cardiol 2004; 25:274–286.
Hernandez E, Figueroa H, Kottman C, Illanes S., et.al. Gestational ageadjusted reference values for the modified myocardial performance index for
evaluation of fetal left cardiac function. Ultrasound Obstet Gynecol 2007; 29:
321–325.
Carceller-Blanchard AM, Fouron JC. Determinants of the Doppler flow velocity
profile through the mitral valve of the human fetus. Br Heart J 1993; 70: 457–
460.
Borrell A, Martinez JM, Serés A, Borobio V,et.al.. Ductus venosus assessment
at the time of nuchal translucency measurement in the detection of fetal
aneuploidy. Prenat Diagn 2003; 23: 921–926.
Maiz N, Plasencia W, Dagklis T, Faros E, et.al.. Ductus venosus Doppler in
fetuses with cardiac defects and increased nuchal translucency thickness.
Ultrasound Obstet Gynecol. 2008; 31: 256–260.
Rozmus-Warcholinska W, Wloch A, Acharya G, Cnota W, Czuba B, Sodowski
K et al. Reference values for variables of fetal cardiocirculatory dynamics at
11-14 weeks of gestation. Ultrasound Obstet.Gynecol. 2010; 35: 540-47.
Royston P, Wright EM. How to construct ‘normal ranges’ for fetal variables.
Ultrasound Obstet Gynecol 1998; 11: 30–38.
ACOG Practice Bulletin No. 101: Ultrasonography in pregnancy.Obstet
Gynecol. 2009 Feb;113 (2 Pt 1):451-61
Autor
Rincón Rodríguez, Carlos Javier
Duque, José Luis
Institución
Resumen
Introducción: El ultrasonido es un método diagnóstico ampliamente usado para evaluación tanto el crecimiento como la anatomía fetal. Es un procedimiento que proporciona hallazgos diagnósticos que pueden facilitar el manejo de problemas a lo largo del embarazo, como son alteraciones del crecimiento fetal que causen aumento de la morbilidad y mortalidad perinatal tanto en los países desarrollados como en vía de desarrollo. La Organización Mundial de la Salud en el 2005, concluyó que las anomalías del crecimiento fetal se relacionaban con múltiples causas como alteraciones genéticas, alteraciones en la nutrición materna, tabaquismo, edad y enfermedades de la madre3. El tamizaje de las anomalías cromosómicas ha sido tema de investigación e interés en el ámbito materno fetal, siendo la ecografía obstétrica temprana (semana 11 a la 14), un método fiable, no invasivo y representa el estudio de elección actual para la estratificación del riesgo fetal. Nota: Para consultar la carta de autorización de publicación de este documento por favor copie y pegue el siguiente enlace en su navegador de internet: http://hdl.handle.net/10818/9432